Patrick Dolezal

Stock Analyst at LifeSci Capital

(2.83)
# 1,888
Out of 5,048 analysts
2
Total ratings
100%
Success rate
26.76%
Average return

Stocks Rated by Patrick Dolezal

Kodiak Sciences
Oct 23, 2025
Initiates: Outperform
Price Target: $40
Current: $18.13
Upside: +120.69%
Avadel Pharmaceuticals
May 2, 2023
Maintains: Outperform
Price Target: $17$26
Current: $18.89
Upside: +37.64%